Jun 16, 2026 08:33AM
Jun 16, 2026 08:33AM
Jun 15, 2026 08:45AM
Jun 15, 2026 08:45AM
Jun 15, 2026 08:45AM
May 28, 2026 08:50AM
May 28, 2026 08:50AM Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipelin
May 8, 2026 04:05PM
Apr 14, 2026 08:45AM
Apr 2, 2026 08:46AM
Apr 2, 2026 08:45AM
Mar 27, 2026 04:05PM
Mar 4, 2026 08:30AM
Mar 4, 2026 08:30AM Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
Feb 11, 2026 09:03AM
Feb 11, 2026 09:00AM
Feb 9, 2026 08:50AM
Feb 9, 2026 08:50AM
Feb 4, 2026 08:02AM
Feb 4, 2026 08:00AM
Jan 21, 2026 08:31AM Entera Bio outlines Q1 2026 milestones for osteoporosis drug
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Dec 24, 2025 06:44AM
Dec 23, 2025 08:30AM
Dec 22, 2025 08:32AM
Dec 22, 2025 08:30AM
Nov 18, 2025 08:00AM Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
Nov 14, 2025 04:05PM
Oct 23, 2025 08:50AM
Oct 23, 2025 08:50AM
Oct 16, 2025 08:45AM
Oct 16, 2025 08:45AM
Sep 15, 2025 09:01AM
Sep 15, 2025 09:00AM Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
Sep 8, 2025 08:32AM
Sep 8, 2025 08:30AM
Aug 28, 2025 08:05AM
Aug 28, 2025 08:00AM
Aug 8, 2025 04:05PM
Jul 28, 2025 07:30AM
Jul 28, 2025 07:30AM Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis
Jul 8, 2025 08:03AM
Jul 8, 2025 08:00AM
Jun 26, 2025 08:00AM
Jun 25, 2025 08:05AM
Jun 25, 2025 08:00AM
May 9, 2025 04:05PM
Apr 15, 2025 08:32AM Entera Bio Ltd. (ENTX) Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis
Apr 15, 2025 08:30AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All